Jfl Capital Management, Llc - Net Worth and Insider Trading
Jfl Capital Management, Llc Net Worth
The estimated net worth of Jfl Capital Management, Llc is at least $19 Million dollars as of 2024-11-10. Jfl Capital Management, Llc is the of Merrimack Pharmaceuticals Inc and owns about 1,249,828 shares of Merrimack Pharmaceuticals Inc (MACK) stock worth over $19 Million. Details can be seen in Jfl Capital Management, Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jfl Capital Management, Llc has not made any transactions after 2019-07-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jfl Capital Management, Llc
Jfl Capital Management, Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jfl Capital Management, Llc owns 2 companies in total, including Merrimack Pharmaceuticals Inc (MACK) , and Catalyst Biosciences Inc (CBIO) .
Click here to see the complete history of Jfl Capital Management, Llc’s form 4 insider trades.
Insider Ownership Summary of Jfl Capital Management, Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MACK | Merrimack Pharmaceuticals Inc | 2019-07-02 | 10 percent owner & other: See Explanation of Responses |
| CBIO | Catalyst Biosciences Inc | 2018-07-26 | other: 5% owner |
Jfl Capital Management, Llc Latest Holdings Summary
Jfl Capital Management, Llc currently owns a total of 1 stock. Jfl Capital Management, Llc owns 1,249,828 shares of Merrimack Pharmaceuticals Inc (MACK) as of July 2, 2019, with a value of $19 Million.
Latest Holdings of Jfl Capital Management, Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MACK | Merrimack Pharmaceuticals Inc | 2019-07-02 | 1,249,828 | 15.13 | 18,909,898 |
Holding Weightings of Jfl Capital Management, Llc
Jfl Capital Management, Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Jfl Capital Management, Llc has made a total of 0 transactions in Merrimack Pharmaceuticals Inc (MACK) over the past 5 years. The most-recent trade in Merrimack Pharmaceuticals Inc is the acquisition of 50,288 shares on July 2, 2019, which cost Jfl Capital Management, Llc around $297,705.
Insider Trading History of Jfl Capital Management, Llc
- 1
Jfl Capital Management, Llc Trading Performance
GuruFocus tracks the stock performance after each of Jfl Capital Management, Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jfl Capital Management, Llc is -12.89%. GuruFocus also compares Jfl Capital Management, Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jfl Capital Management, Llc within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jfl Capital Management, Llc's insider trading performs compared to the benchmark.
Performance of Jfl Capital Management, Llc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.56 | | | | | |
| Relative Return to S&P 500(%) | 5.53 | | | | | |
Jfl Capital Management, Llc Ownership Network
Ownership Network List of Jfl Capital Management, Llc
Ownership Network Relation of Jfl Capital Management, Llc
Jfl Capital Management, Llc Owned Company Details
What does Merrimack Pharmaceuticals Inc do?
Who are the key executives at Merrimack Pharmaceuticals Inc?
Jfl Capital Management, Llc is the 10 percent owner & other: See Explanation of Responses of Merrimack Pharmaceuticals Inc. Other key executives at Merrimack Pharmaceuticals Inc include director & other: See Remarks Eric Andersen , director & President Gary L Crocker , and director & other: See Remarks Noah G. Levy .
Merrimack Pharmaceuticals Inc (MACK) Insider Trades Summary
Over the past 18 months, Jfl Capital Management, Llc made no insider transaction in Merrimack Pharmaceuticals Inc (MACK). Other recent insider transactions involving Merrimack Pharmaceuticals Inc (MACK) include a net purchase of 446,418 shares made by Eric Andersen , and a net purchase of 4,000 shares made by Gary L Crocker .
In summary, during the past 3 months, insiders sold 0 shares of Merrimack Pharmaceuticals Inc (MACK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Merrimack Pharmaceuticals Inc (MACK) were sold and 450,418 shares were bought by its insiders, resulting in a net purchase of 450,418 shares.
Merrimack Pharmaceuticals Inc (MACK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Merrimack Pharmaceuticals Inc Insider Transactions
Jfl Capital Management, Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Jfl Capital Management, Llc. You might contact Jfl Capital Management, Llc via mailing address: 2110 Ranch Road 620 S 341732, Lakeway Tx 78734.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
